MCD P/E Ratio Analysis
Updated 81h ago·SEC filings & market data
Key Takeaway
A P/E ratio of 21.9x means investors pay $21.90 for each $1 of the company's annual earnings per share.
Sector Performance
46th percentileMCD
21.9x
Sector Median
23.1x
Sector Avg
33.7x
Prior Period
21.9x(Aug 2026)
Deep Analysis
A P/E ratio of 21.9x means investors pay $21.90 for each $1 of the company's annual earnings per share.
Compared to sector peers, this sits below the sector median of 23.2x and falls at the 45th percentile, placing MCD slightly cheaper than the typical peer. For the trend, the year-over-year change is not available (N/A), while the quarter-over-quarter change is -1.4%, reflecting a decline from the prior value of 22.2x. The combination of a valuation just under the sector norm and a small quarterly dip suggests modest pressure on the multiple rather than a major repricing. This creates limited near-term downside from valuation alone, but also offers no clear bargain advantage. The metric supports the overall NEUTRAL verdict, as the level and trend are neither compellingly cheap nor dangerously expensive.
Frequently Asked Questions
What does the P/E Ratio tell investors about MCD?
Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.
How is the P/E Ratio calculated?
P/E Ratio is calculated as: Price / EPS.
Who are MCD's closest peers by P/E Ratio?
The closest peers by P/E Ratio include: WELL (102.4x), IAC (104.9x), FORM (108.1x), MCHP (113.5x), MTSI (118.9x).
Learn More About P/E Ratio
The Formula
Price / EPS
Why It Matters
Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.
Master MCD's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full MCD research report →MCD
21.9x
Sector Median
23.1x
Sector Avg
33.7x
How MCD's P/E Ratio compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.